이뮤노글로불린-유사 전사체 3 (ILT3)에 대해 특이적인 항체 및 그의 용도

백혈구 이뮤노글로불린-유사 수용체 서브패밀리 B 구성원 4 (LILRB4)로도 공지된 이뮤노글로불린-유사 전사체 3 (ILT3)에 대해 특이적인 인간화, 비-무차별적인 모노클로날 항체가 기재된다. Humanized, non-promiscuous monoclonal antibodies specific for immunoglobulin-like transcript 3 (ILT3), also known as Leukocyte immunoglobulin-like receptor subfamily B member 4 (LILRB4), are...

Full description

Saved in:
Bibliographic Details
Main Authors MEEHL MICHAEL A, SINGH LATIKA, FAYADAT DILMAN LAURENCE, BRANDISH PHILIP E, MIECZKOWSKI CARL, JUAN VERONICA
Format Patent
LanguageKorean
Published 08.07.2020
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:백혈구 이뮤노글로불린-유사 수용체 서브패밀리 B 구성원 4 (LILRB4)로도 공지된 이뮤노글로불린-유사 전사체 3 (ILT3)에 대해 특이적인 인간화, 비-무차별적인 모노클로날 항체가 기재된다. Humanized, non-promiscuous monoclonal antibodies specific for immunoglobulin-like transcript 3 (ILT3), also known as Leukocyte immunoglobulin-like receptor subfamily B member 4 (LILRB4), are described.
Bibliography:Application Number: KR20207016922